HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion.

Abstract
Two doses, 200 and 400 micrograms, of misoprostol, administered vaginally every 12 hours, up to four times, were tested in 101 and 133 healthy women, respectively, for interruption of pregnancies with 35 through 77 days of amenorrhea. The proportion of women who aborted increased with longer duration of treatment and was significantly higher with 400 than with 200 micrograms (66 versus 46 percent at 48 hours). Significance was maintained after controlling by age, body weight, parity, previous abortion and gestational age. Abortions were classified as incomplete or complete, according to the presence or not of embryonic tissue in the uterine cavity, diagnosed by vaginal sonography. Vacuum aspiration was carried out in all cases not classified as complete abortion 48 hours after the initiation of treatment, or earlier in case of persistent bleeding or woman's request. The possibility of increasing effectiveness by using higher dose, shorter intervals or longer duration of treatment is discussed.
AuthorsA Bugalho, A Faúndes, L Jamisse, M Usfá, E Maria, C Bique
JournalContraception (Contraception) Vol. 53 Issue 4 Pg. 244-6 (Apr 1996) ISSN: 0010-7824 [Print] United States
PMID8706443 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Abortifacient Agents, Nonsteroidal
  • Misoprostol
Topics
  • Abortifacient Agents, Nonsteroidal (administration & dosage)
  • Abortion, Incomplete (diagnostic imaging)
  • Abortion, Induced
  • Administration, Intravaginal
  • Adolescent
  • Adult
  • Female
  • Humans
  • Misoprostol (administration & dosage, adverse effects)
  • Pregnancy
  • Pregnancy Trimester, First
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: